AMCo wraps up lev loan after reverse flex
UK generic pharmaceuticals company Amdipharm Mercury — also known as AMCo — is closing books on a €163.7m leveraged, having tightened pricing on the back of strong demand.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: